Komori
Pharma Foods International (2929) · InitiativeFirst stated

Developing Lactron tablets into the next flagship product

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Developing Lactron tablets into the next flagship productA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「The quasi-drug Lactron tablets have gained market penetration, with sales increasing substantially to 112% of the level in the same period of the previous year.」

    Lactron tablets expanded sales as a potential new earnings pillar and began to be positioned as the next core product following the Nyu-mo series.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Pharma Foods International yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.